Cargando…

Treat patient, not just the disease: holistic needs assessment for haematological cancer patients

Haematological malignancies can have devastating effects on the patients’ physical, emotional, psycho-sexual, educational and economic health. With the improvement of therapies patients with these malignancies are living longer, however significant proportion these patient show poor quality of life...

Descripción completa

Detalles Bibliográficos
Autor principal: Islam, Md Serajul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151346/
https://www.ncbi.nlm.nih.gov/pubmed/30283608
http://dx.doi.org/10.4081/oncol.2018.374
_version_ 1783357133124796416
author Islam, Md Serajul
author_facet Islam, Md Serajul
author_sort Islam, Md Serajul
collection PubMed
description Haematological malignancies can have devastating effects on the patients’ physical, emotional, psycho-sexual, educational and economic health. With the improvement of therapies patients with these malignancies are living longer, however significant proportion these patient show poor quality of life (QoL) due to various physical and psychological consequences of the disease and the treatments. Health-related QoL (HRQoL) is multi-dimensional and temporal, relating to a state of functional, physical, psychological and social/family well-being. Compared with the general population, HRQoL of these patients is worse in most dimensions. However without routine holistic need assessment (HNA), clinicians are unlikely to identify patients with clinically significant distress. Surviving cancer is a chronic life-altering condition with several factors negatively affecting their QoL, such as psychological problems, including depression and excessive fear of recurrence, as well as social aspects, such as unemployment and social isolation. These need to be adequately understood and addressed in the healthcare of long-term survivors of haematological cancer. Applying a holistic approach to patient care has many benefits and yet, only around 25% of cancer survivors in the UK receive a holistic needs assessment. The efforts of the last decade have established the importance of ensuring access to psychosocial services for haematological cancer survivors. We need to determine the most effective practices and how best to deliver them across diverse settings. Distress, like haematological cancer, is not a single entity, and one treatment does not fit all. Psychosocialoncology needs to increase its research in comparative effectiveness.
format Online
Article
Text
id pubmed-6151346
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-61513462018-10-03 Treat patient, not just the disease: holistic needs assessment for haematological cancer patients Islam, Md Serajul Oncol Rev Review Haematological malignancies can have devastating effects on the patients’ physical, emotional, psycho-sexual, educational and economic health. With the improvement of therapies patients with these malignancies are living longer, however significant proportion these patient show poor quality of life (QoL) due to various physical and psychological consequences of the disease and the treatments. Health-related QoL (HRQoL) is multi-dimensional and temporal, relating to a state of functional, physical, psychological and social/family well-being. Compared with the general population, HRQoL of these patients is worse in most dimensions. However without routine holistic need assessment (HNA), clinicians are unlikely to identify patients with clinically significant distress. Surviving cancer is a chronic life-altering condition with several factors negatively affecting their QoL, such as psychological problems, including depression and excessive fear of recurrence, as well as social aspects, such as unemployment and social isolation. These need to be adequately understood and addressed in the healthcare of long-term survivors of haematological cancer. Applying a holistic approach to patient care has many benefits and yet, only around 25% of cancer survivors in the UK receive a holistic needs assessment. The efforts of the last decade have established the importance of ensuring access to psychosocial services for haematological cancer survivors. We need to determine the most effective practices and how best to deliver them across diverse settings. Distress, like haematological cancer, is not a single entity, and one treatment does not fit all. Psychosocialoncology needs to increase its research in comparative effectiveness. PAGEPress Publications, Pavia, Italy 2018-07-04 /pmc/articles/PMC6151346/ /pubmed/30283608 http://dx.doi.org/10.4081/oncol.2018.374 Text en ©Copyright Md S. Islam, 2018 http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0).
spellingShingle Review
Islam, Md Serajul
Treat patient, not just the disease: holistic needs assessment for haematological cancer patients
title Treat patient, not just the disease: holistic needs assessment for haematological cancer patients
title_full Treat patient, not just the disease: holistic needs assessment for haematological cancer patients
title_fullStr Treat patient, not just the disease: holistic needs assessment for haematological cancer patients
title_full_unstemmed Treat patient, not just the disease: holistic needs assessment for haematological cancer patients
title_short Treat patient, not just the disease: holistic needs assessment for haematological cancer patients
title_sort treat patient, not just the disease: holistic needs assessment for haematological cancer patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151346/
https://www.ncbi.nlm.nih.gov/pubmed/30283608
http://dx.doi.org/10.4081/oncol.2018.374
work_keys_str_mv AT islammdserajul treatpatientnotjustthediseaseholisticneedsassessmentforhaematologicalcancerpatients